Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54,486,781
-
Number of holders
-
204
-
Total 13F shares, excl. options
-
35,742,013
-
Shares change
-
-132,192
-
Total reported value, excl. options
-
$1,173,028,889
-
Value change
-
-$3,279,137
-
Put/Call ratio
-
59.53%
-
Number of buys
-
103
-
Number of sells
-
-94
-
Price
-
$32.84
Significant Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q4 2016
238 filings reported holding EBS - Emergent BioSolutions Inc. - Common Stock as of Q4 2016.
Emergent BioSolutions Inc. - Common Stock (EBS) has 204 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35,742,013 shares
of 54,486,781 outstanding shares and own 65.6% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3,535,006 shares), BlackRock Fund Advisors (2,663,371 shares), DIMENSIONAL FUND ADVISORS LP (2,025,318 shares), GLENMEDE TRUST CO NA (1,470,747 shares), ACADIAN ASSET MANAGEMENT LLC (1,381,352 shares), ABERDEEN ASSET MANAGEMENT PLC/UK (1,248,668 shares), STATE STREET CORP (1,238,972 shares), SNYDER CAPITAL MANAGEMENT L P (962,696 shares), RENAISSANCE TECHNOLOGIES LLC (883,511 shares), and BlackRock Institutional Trust Company, N.A. (861,799 shares).
This table shows the top 204 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.